Mutagenicity of 1-fluoro-2,4-dinitrobenzene is affected by bacterial glutathione.
Recently we have shown that Salmonella typhimurium tester strains have high levels of the tripeptide glutathione (GSH) and activity of GSH S-transferases (Summer et al., 1979). In continuation of the GSH-dependent suppression of mutagenicity of 1-chloro-2,4-dinitrobenzene in presence of S9 fraction (Summer et al., 1979), this paper is focused on the GSH-dependent detoxifying capacity of the bacterial tester strains. 1-Fluoro-2,4-dinitrobenzene (FDNB), an electrophilic agent, which is used to identify terminal amino acids in proteins (Sanger reagent), readily reacts with GSH leading to a dose-dependent  depletion of bacterial GSH. Additionally, FDNB is a strong mutagen for Salmonella typhimurium TA100, TA1538, and TA98 without metabolic activation. Presumably owing to conjugation with bacterial GHS, FDNB in concentrations which were lower or equal to those of bacterial GSH were found to be not mutagenic. Accordingly, increasing amounts of bacteria in the test system require increasing amounts of FDNB for expression of mutagenicity.
D004136:Dinitrobenzenes / Q000378:metabolism / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005978:Glutathione / Q000235:genetics* / Q000378:metabolism; D009153:Mutagens; D009578:Nitrobenzenes / Q000494:pharmacology*; D010641:Phenotype; D012486:Salmonella typhimurium / Q000235:genetics* / Q000378:metabolism
D004136:Dinitrobenzenes; D009153:Mutagens; D009578:Nitrobenzenes; D005978:Glutathione